Relay Therapeutics, Inc. - Common Stock, $0.01 par value (RLAY)
CUSIP: 75943R102
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.01 par value
- Shares outstanding
- 4,389,099
- Total 13F shares
- 170,927,354
- Share change
- +8,246,591
- Total reported value
- $591,366,333
- Price per share
- $3.46
- Number of holders
- 203
- Value change
- +$36,190,035
- Number of buys
- 105
- Number of sells
- 87
Quarterly Holders Quick Answers
What is CUSIP 75943R102?
CUSIP 75943R102 identifies RLAY - Relay Therapeutics, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75943R102:
Top shareholders of RLAY - Relay Therapeutics, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD |
13F
|
Company |
636%
|
27,904,963
|
$73,111,003 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13D/G
13F
|
Company |
7.8%
|
13,445,704
|
$50,152,476 | +$13,993,047 | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
6.1%
from 13D/G
|
14,478,798
|
$37,934,451 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
276%
|
12,105,420
|
$31,716,201 | — | 31 Mar 2025 | |
| Casdin Capital, LLC |
13F
|
Company |
207%
|
9,098,574
|
$23,838,264 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
184%
|
8,068,058
|
$21,138,312 | — | 31 Mar 2025 | |
| Bellevue Group AG |
13F
|
Company |
168%
|
7,377,292
|
$19,328,505 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
118%
|
5,159,192
|
$13,517,083 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
112%
|
4,909,771
|
$12,863,601 | — | 31 Mar 2025 | |
| Nextech Invest, Ltd. |
13F
|
Company |
88%
|
3,846,409
|
$10,077,592 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
79%
|
3,477,791
|
$9,113,000 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
70%
|
3,070,118
|
$8,045,535 | — | 31 Mar 2025 | |
| Kynam Capital Management, LP |
13F
|
Company |
70%
|
3,063,292
|
$8,025,825 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
67%
|
2,942,875
|
$7,710,333 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
64%
|
2,799,091
|
$7,334,224 | — | 31 Mar 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
61%
|
2,682,083
|
$7,027,057 | — | 31 Mar 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
52%
|
2,295,924
|
$6,015,321 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
52%
|
2,276,110
|
$5,963,408 | — | 31 Mar 2025 | |
| Finepoint Capital LP |
13F
|
Company |
48%
|
2,117,646
|
$5,548,233 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
47%
|
2,077,995
|
$5,444,347 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
36%
|
1,593,186
|
$4,174,147 | — | 31 Mar 2025 | |
| Alphabet Inc. |
13F
|
Company |
36%
|
1,568,753
|
$4,110,133 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
35%
|
1,518,561
|
$3,978,630 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
26%
|
1,160,117
|
$3,039,507 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
26%
|
1,142,928
|
$2,994,472 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
24%
|
1,064,858
|
$2,789,928 | — | 31 Mar 2025 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
23%
|
1,000,000
|
$2,620,000 | — | 31 Mar 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
21%
|
931,251
|
$2,440,000 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
19%
|
843,856
|
$2,210,903 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
17%
|
751,200
|
$1,968,144 | — | 31 Mar 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
17%
|
743,308
|
$1,947,467 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
16%
|
682,028
|
$1,785,000 | — | 31 Mar 2025 | |
| EcoR1 Capital, LLC |
13F
|
Company |
15%
|
641,426
|
$1,680,536 | — | 31 Mar 2025 | |
| Tetragon Partners GP Ltd |
13F
|
Company |
14%
|
619,000
|
$1,621,780 | — | 31 Mar 2025 | |
| BESSEMER GROUP INC |
13F
|
Company |
13%
|
584,530
|
$1,531,000 | — | 31 Mar 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
13%
|
580,136
|
$1,520,035 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
13%
|
554,428
|
$1,452,602 | — | 31 Mar 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
12%
|
541,124
|
$1,417,745 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
11%
|
469,171
|
$1,229,229 | — | 31 Mar 2025 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
10%
|
460,000
|
$1,205,200 | — | 31 Mar 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
9.8%
|
431,150
|
$1,129,613 | — | 31 Mar 2025 | |
| DIADEMA PARTNERS LP |
13F
|
Company |
9.7%
|
426,346
|
$1,117,027 | — | 31 Mar 2025 | |
| DARK FOREST CAPITAL MANAGEMENT LP |
13F
|
Company |
9.3%
|
405,995
|
$1,063,707 | — | 31 Mar 2025 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
9%
|
393,375
|
$1,030,643 | — | 31 Mar 2025 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
8.7%
|
382,900
|
$1,003,198 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
8.5%
|
372,353
|
$975,565 | — | 31 Mar 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
8.4%
|
368,579
|
$965,000 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
8.3%
|
364,946
|
$956,159 | — | 31 Mar 2025 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
8.1%
|
356,165
|
$933,152 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
7.7%
|
337,268
|
$883,642 | — | 31 Mar 2025 |
Institutional Holders of Relay Therapeutics, Inc. - Common Stock, $0.01 par value (RLAY) as of Q2 2025
As of 30 Jun 2025,
Relay Therapeutics, Inc. - Common Stock, $0.01 par value (RLAY) was held by
203 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
170,927,354 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, BlackRock, Inc., Point72 Asset Management, L.P., Commodore Capital LP, Casdin Capital, LLC, VANGUARD GROUP INC, Bellevue Group AG, TANG CAPITAL MANAGEMENT LLC, STATE STREET CORP, and JPMORGAN CHASE & CO.
This page lists
204
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
205
Q2 2025 holders
203
Holder diff
-2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.